Propionyl-L-carnitine for intermittent claudication.
- 2021-12-26
- Meta-Analysis · n = 1,395
- The Cochrane database of systematic reviews 2021(12)
- Victor Kamoen
- Robert Vander Stichele
- Laurence Campens
- Dirk De Bacquer
- Luc Van Bortel
- Tine Lm de Backer
- PubMed: 34954832
- DOI: 10.1002/14651858.cd010117.pub2
- High evidence
- Clinical
We found no evidence of a clear difference in the ICD (absolute improvement 4.00 meters, 95% CI -9.86 to 17.86; 1 study, 14 participants); or a 3% relative improvement (95% CI -7.4% to 13.4%).
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- not stated (comparator in single cross-over study)